ATE319833T1 - Impfstoffe zur erhöhung der immunantworten gegen herpes simplex virus - Google Patents

Impfstoffe zur erhöhung der immunantworten gegen herpes simplex virus

Info

Publication number
ATE319833T1
ATE319833T1 AT00983967T AT00983967T ATE319833T1 AT E319833 T1 ATE319833 T1 AT E319833T1 AT 00983967 T AT00983967 T AT 00983967T AT 00983967 T AT00983967 T AT 00983967T AT E319833 T1 ATE319833 T1 AT E319833T1
Authority
AT
Austria
Prior art keywords
type
hsv
nucleic acid
protein
mammal
Prior art date
Application number
AT00983967T
Other languages
English (en)
Inventor
Eric M Mishkin
Robert J Natuk
Michael W Pride
Maninder K Sidhu
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE319833T1 publication Critical patent/ATE319833T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55538—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00983967T 1999-12-17 2000-12-07 Impfstoffe zur erhöhung der immunantworten gegen herpes simplex virus ATE319833T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17231399P 1999-12-17 1999-12-17

Publications (1)

Publication Number Publication Date
ATE319833T1 true ATE319833T1 (de) 2006-03-15

Family

ID=22627181

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00983967T ATE319833T1 (de) 1999-12-17 2000-12-07 Impfstoffe zur erhöhung der immunantworten gegen herpes simplex virus

Country Status (16)

Country Link
EP (1) EP1238086B1 (de)
JP (1) JP2003517042A (de)
KR (1) KR100773390B1 (de)
CN (1) CN1222619C (de)
AT (1) ATE319833T1 (de)
AU (1) AU783730B2 (de)
BR (1) BR0016419A (de)
CA (1) CA2406678A1 (de)
CY (1) CY1105604T1 (de)
DE (1) DE60026588T2 (de)
DK (1) DK1238086T3 (de)
ES (1) ES2258987T3 (de)
IL (1) IL149810A0 (de)
MX (1) MXPA02005867A (de)
PT (1) PT1238086E (de)
WO (1) WO2001044477A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100443116C (zh) * 2002-11-07 2008-12-17 新纳几美国公司 治疗或预防肺炎球菌感染的组合物及其用途
CN102458463B (zh) 2009-05-22 2017-01-18 健诺西生物科学公司 针对ⅱ型单纯疱疹病毒的疫苗：诱发免疫应答的组合物和方法
KR101008582B1 (ko) * 2010-09-20 2011-01-17 (주)칠칠공사 달비계용 2중 안전 샤클조립체
CA2856697A1 (en) 2010-11-24 2012-06-07 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
JP6199878B2 (ja) * 2011-11-23 2017-09-20 ジェノセア バイオサイエンシーズ， インコーポレイテッド 単純ヘルペスウイルス２型に対する核酸ワクチン：免疫応答を誘発する組成物及び方法
DK2941269T3 (da) 2013-01-07 2021-01-11 Mucosal Vaccine Tech Llc Terapeutiske vacciner til behandling af herpes simplex-virus type 2-infektioner
WO2015134368A2 (en) 2014-03-03 2015-09-11 Albert Einstein College Of Medicine Of Yeshiva University Recombinant herpes simplex virus 2 (hsv-2) vaccine vectors
US10918712B2 (en) 2014-03-03 2021-02-16 Albert Einstein College Of Medicine Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
CN104721839A (zh) * 2015-03-17 2015-06-24 浙江省医学科学院 一种预防单纯疱疹病毒ii型的疫苗
CN104830781A (zh) * 2015-05-05 2015-08-12 杨光华 基于hsv-2抗原的dc细胞、靶向性免疫细胞群及其制备方法和用途
US10350288B2 (en) 2016-09-28 2019-07-16 Genocea Biosciences, Inc. Methods and compositions for treating herpes
WO2019016109A1 (en) * 2017-07-17 2019-01-24 Chu De Nantes - Centre Hospitalier Unversitaire De Nantes INTERLEUKINE 12 (IL12) OR DERIVATIVE THEREOF FOR USE IN THE TREATMENT OF A SECONDARY DISEASE
CN111051333B (zh) * 2017-08-30 2024-04-05 Km生物医薬股份公司 修饰型HSV gD蛋白及包含其的疫苗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9907883A (pt) * 1998-02-12 2000-11-14 American Cyanamid Co Composição de vacina, processo para eliciar uma resposta imune a um antìgeno de vìrus de herpes simplex, e, composição imunogênica

Also Published As

Publication number Publication date
DK1238086T3 (da) 2006-06-26
AU783730B2 (en) 2005-12-01
DE60026588T2 (de) 2007-01-18
KR100773390B1 (ko) 2007-11-09
KR20020073348A (ko) 2002-09-23
EP1238086A1 (de) 2002-09-11
ES2258987T3 (es) 2006-09-16
PT1238086E (pt) 2006-07-31
MXPA02005867A (es) 2002-10-23
CN1434864A (zh) 2003-08-06
IL149810A0 (en) 2002-11-10
BR0016419A (pt) 2002-08-20
DE60026588D1 (de) 2006-05-04
CA2406678A1 (en) 2001-06-21
AU2065101A (en) 2001-06-25
JP2003517042A (ja) 2003-05-20
WO2001044477A1 (en) 2001-06-21
CN1222619C (zh) 2005-10-12
CY1105604T1 (el) 2010-07-28
EP1238086B1 (de) 2006-03-08

Similar Documents

Publication Publication Date Title
KR0176265B1 (en) Causative agent of the mystery swine disease, and vaccine compositions
FI953608A7 (fi) Rokoteyhdisteet ja menetelmä immuunireaktion aikaansaamiseksi limakalv ossa järjestelmällisellä rokottamisella
DK0835133T3 (da) Rekombinant koppevirus-rabies-præparater og kombinationspræparater samt anvendelser deraf
DE60026588D1 (de) Impfstoffe zur erhöhung der immunantworten gegen herpes simplex virus
CA2660355A1 (en) Polynucleotide vaccine formulation against pathologies of the horse
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
BRPI0408779A (pt) uso de composições, composição imunogênica e kit
EP1847549A3 (de) Polyproteinkonstrukte des Papillomavirus
NZ319377A (en) polypeptides comprising a portion of a soluble M tuberculosis antigen
EP2172551A3 (de) Verbindungen zur Immuntherapie und Diagnose von Tuberkulose und Verfahren zu deren Verwendung
BG101103A (bg) Теломераза при бозайници
FR2814958B1 (fr) Composition vaccinale
MX9401225A (es) Composicion de vacuna para prevenir la infeccion con influenza en humanos y metodo para su preparacion.
WO2002024739A3 (en) Spas-1 cancer antigen
BR0014138A (pt) Uso de um vetor adenoviral deficiente em replicação, e, métodos para reforçar, e para induzir resposta imune de célula cd8+ t a um antìgeno em um indivìduo
DK1053017T3 (da) Vacciner omfattende interleukin-12 og herpes simplex virusantigen
WO1999053960A3 (en) Enhancing immune responses to genetic immunization by using a chemokine
AU8467201A (en) Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses
DE69922804D1 (de) Verwendung von polymeren der hyaluronsäure zur mukosalen freigabe von impfstoffen und adjuvantien
DK0524421T3 (da) Humant herpesvirus type 6 protein p 100, de tilsvarende DNA-sekvenser, deres fremstilling og anvendelse
ATE374622T1 (de) Genetische impstoffe mit adjuvans
BR9905780A (pt) Antìgenos vacinais de leptospira para prevenção da laptospirose
BR0016740A (pt) Antìgenos de esporozoìto de cryptosporidium
ES2105984A1 (es) Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
WO1998058954A3 (en) Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1238086

Country of ref document: EP

REN Ceased due to non-payment of the annual fee